Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis

被引：38
|
作者：
Han, Jinmin [2 ,3 ,4 ]
Wang, Zhongtang [3 ,4 ]
Liu, Chengxin [1 ,3 ,4 ,5 ]
机构：
[1] Shandong Univ, Cheeloo Coll Med, Jinan 250012, Peoples R China
[2] Shandong First Med Univ, Jinan 250117, Peoples R China
[3] Shandong Acad Med Sci, Jinan 250117, Peoples R China
[4] Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Peoples R China
[5] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Peoples R China
来源：
FUTURE ONCOLOGY | 2021年 / 17卷 / 17期
基金：
中国国家自然科学基金;
关键词：
complications; esophageal cancer; meta-analysis; neoadjuvant treatment; survival; PHASE-III TRIAL; PREOPERATIVE CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; RESECTABLE ESOPHAGEAL; CHEMORADIATION; THERAPY; ADENOCARCINOMA; CARCINOMA; SURGERY; RADIOCHEMOTHERAPY;
D O I：
10.2217/fon-2021-0021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objectives: To identify the effective approach between neoadjuvant chemotherapy (NCT) and chemoradiotherapy (NCRT) by comparing patient survival and complications. Methods: A systematic literature search of articles published between January 1980 and October 2020 was conducted. Data were extracted and analyzed with STATA 12.0. Results: Five randomized trials and 15 retrospective studies, including 4529 patients (NCT: 2035; NCRT: 2494), were enrolled. Compared with NCT, NCRT provided a higher 3-year survival benefit, higher R0 resection and pathological complete response rates and lower local recurrence and distant metastasis rates, but no increase in 5-year survival. Perioperative mortality and cardiovascular complications were more common in patients with adenocarcinoma. Conclusions: Further studies should concentrate on identifying the optimal neoadjuvant approach and suitable beneficiaries.
引用
收藏
页码：2257 / 2274
页数：18
相关论文
共 50 条
  • [31] A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
    Klevebro, F.
    von Dobeln, G. Alexandersson
    Wang, N.
    Johnsen, G.
    Jacobsen, A. -B.
    Friesland, S.
    Hatlevoll, I.
    Glenjen, N. I.
    Lind, P.
    Tsai, J. A.
    Lundell, L.
    Nilsson, M.
    ANNALS OF ONCOLOGY, 2016, 27 (04) : 660 - 667
  • [32] Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer
    Bohle, Wolfram
    Kasper, Michaela
    Zoller, Wolfram G.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (07): : 2922 - 2928
  • [33] Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer
    Zhu, Yusen
    Liu, Min
    Yun, Xiaojing
    Wang, Dongmei
    Bai, Yuhuan
    Zhang, Guizhi
    Ji, Bei
    Jing, Changchun
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (03) : 657 - 663
  • [34] Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
    Hulshoff, J. B.
    Faiz, Z.
    Karrenbeld, A.
    Kats-Ugurlu, G.
    Burgerhof, J. G. M.
    Smit, J. K.
    Plukker, J. Th. M.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1301 - S1309
  • [35] Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer Impact of Histology on Recurrence Patterns and Outcomes
    Xi, Mian
    Yang, Yadi
    Zhang, Li
    Yang, Hong
    Merrell, Kenneth W.
    Hallemeier, Christopher L.
    Shen, Robert K.
    Haddock, Michael G.
    Hofstetter, Wayne L.
    Maru, Dipen M.
    Ho, Linus
    Wu, Carol C.
    Liu, Mengzhong
    Lin, Steven H.
    ANNALS OF SURGERY, 2019, 269 (04) : 663 - 670
  • [36] Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
    Faron, Matthieu
    Cheugoua-Zanetsie, Maurice
    Tierney, Jayne
    Thirion, Pierre
    Nankivell, Matthew
    Winter, Kathryn
    Yang, Hong
    Shapiro, Joel
    Vernerey, Dewi
    Smithers, B. Mark
    Walsh, Thomas
    Piessen, Guillaume
    Nilsson, Magnus
    Boonstra, Jurjen
    Ychou, Marc
    Law, Simon
    Cunningham, David
    de Vathaire, Florent
    Stahl, Michael
    Urba, Susan
    Valmasoni, Michele
    Williaume, Daniele
    Thomas, Janine
    Lordick, Florian
    Tepper, Joel
    Roth, Jack
    Gebski, Val
    Burmeister, Bryan
    Paoletti, Xavier
    van Sandick, Johanna
    Fu, Jianhua
    Pignon, Jean-Pierre
    Ducreux, Michel
    Michiels, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (28) : 4535 - +
  • [37] Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis
    Ma, Hai-Feng
    Lv, Guo-Xiao
    Cai, Zhong-Fang
    Zhang, Da-Hai
    ONCOTARGETS AND THERAPY, 2018, 11 : 3441 - 3447
  • [38] Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis
    Chan, Kelvin K. W.
    Saluja, Ronak
    Delos Santos, Keemo
    Lien, Kelly
    Shah, Keya
    Cramarossa, Gemma
    Zhu, Xiaofu
    Wong, Rebecca K. S.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (02) : 430 - 437
  • [39] Neoadjuvant chemotherapy with or without neoadjuvant radiotherapy compared with neoadjuvant chemoradiotherapy for esophageal cancer
    Zheng, Yan
    Liu, Xianben
    Zhang, Ruixiang
    Wang, Zongfei
    Sun, Haibo
    Qin, Jianjun
    Liu, Shilei
    Li, Yin
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4715 - 4723
  • [40] Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer
    Zhang, Z.
    Zhang, H.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (04) : 1 - 7
12345